CLCN2

From The Right Wiki
Revision as of 12:40, 10 November 2024 by imported>Bennie1914 (Added new findings about the role of CLCN2 in primary hyperaldosteronism, a hereditary form of hypertension.)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigationJump to search

An Error has occurred retrieving Wikidata item for infobox Chloride channel protein 2 is a protein that in humans is encoded by the CLCN2 gene.[1][2] Mutations of this gene have been found to cause leukoencephalopathy[3] and Idiopathic generalised epilepsy (OMIM: 600699),[4] although the latter claim has been disputed.[5] A gain of function mutation in the CLCN2 gene was found to cause primary aldosteronism,[6] a form of arterial hypertension due to excessive production of aldosterone by the neuroendocrine cells of the zona glomerulosa of the adrenal gland. The mutation was found to cause a chloride leak in these cells and increased the expression of aldosterone synthase.[7] CLCN2 contains a transmembrane region that is involved in chloride ion transport as well two intracellular copies of the CBS domain.

See also

References

  1. Cid LP, Montrose-Rafizadeh C, Smith DI, Guggino WB, Cutting GR (March 1995). "Cloning of a putative human voltage-gated chloride channel (CIC-2) cDNA widely expressed in human tissues". Human Molecular Genetics. 4 (3): 407–13. doi:10.1093/hmg/4.3.407. PMID 7795595.
  2. "Entrez Gene: CLCN2 chloride channel 2".
  3. Depienne C, Bugiani M, Dupuits C, Galanaud D, Touitou V, Postma N, et al. (July 2013). "Brain white matter oedema due to ClC-2 chloride channel deficiency: an observational analytical study". The Lancet. Neurology. 12 (7): 659–68. doi:10.1016/S1474-4422(13)70053-X. hdl:11858/00-001M-0000-0018-F3BD-9. PMID 23707145. S2CID 16634353.
  4. Combi R, Grioni D, Contri M, Redaelli S, Redaelli F, Bassi MT, et al. (April 2009). "Clinical and genetic familial study of a large cohort of Italian children with idiopathic epilepsy". Brain Research Bulletin. 79 (2): 89–96. doi:10.1016/j.brainresbull.2009.01.008. PMID 19200853. S2CID 3036929.
  5. Niemeyer MI, Cid LP, Sepúlveda FV, Blanz J, Auberson M, Jentsch TJ (January 2010). "No evidence for a role of CLCN2 variants in idiopathic generalized epilepsy". Nature Genetics. 42 (1): 3. doi:10.1038/ng0110-3. PMID 20037607.
  6. Fernandes-Rosa, Fabio L.; Daniil, Georgios; Orozco, Ian J.; Göppner, Corinna; El Zein, Rami; Jain, Vandana; Boulkroun, Sheerazed; Jeunemaitre, Xavier; Amar, Laurence; Lefebvre, Hervé; Schwarzmayr, Thomas; Strom, Tim M.; Jentsch, Thomas J.; Zennaro, Maria-Christina (March 2018). "A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism". Nature Genetics. 50 (3): 355–361. doi:10.1038/s41588-018-0053-8. ISSN 1546-1718.
  7. Stowasser, Michael; Wolley, Martin; Wu, Aihua; Gordon, Richard D.; Schewe, Julia; Stölting, Gabriel; Scholl, Ute I. (April 2019). "Pathogenesis of Familial Hyperaldosteronism Type II: New Concepts Involving Anion Channels". Current Hypertension Reports. 21 (4). doi:10.1007/s11906-019-0934-y. ISSN 1522-6417.

Further reading

External links

This article incorporates text from the United States National Library of Medicine, which is in the public domain.